Jens J. Holst

Top papers

• The Physiology of Glucagon-like Peptide 1

  Jens J. Holst·2007·Physiological Reviews
  ↗ 3,218
• Type 2 diabetes mellitus

  Ralph A. DeFronzo, Ele Ferrannini, Leif Groop, et al.·2015·Nature Reviews Disease Primers
  ↗ 2,496
• Glucagon-like peptide 1 (GLP-1)

  Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.·2019·Molecular Metabolism
  ↗ 1,680OA
• Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

  Michael A. Nauck, Markus M. Heimesaat, Cathrine Ørskov, et al.·1993·Journal of Clinical Investigation
  ↗ 1,638OA
• Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

  Anne Flint, Anne Raben, Arne Astrup, et al.·1998·Journal of Clinical Investigation
  ↗ 1,387OA
• Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

  Mette Zander, Sten Madsbad, Jan Lysgaard Madsen, et al.·2002·The Lancet
  ↗ 1,297
• Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients

  Michael A. Nauck, N. Kleine, C. �rskov, et al.·1993·Diabetologia
  ↗ 1,090OA
• Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition

  Ruud S. Kootte, Evgeni Levin, Jarkko Salojärvi, et al.·2017·Cell Metabolism
  ↗ 989OA
• Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations

  Ewan R. Pearson, Isabelle Flechtner, Pål R. Njølstad, et al.·2006·New England Journal of Medicine
  ↗ 982OA
• Inhibition of gastric inhibitory polypeptide signaling prevents obesity

  Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, et al.·2002·Nature Medicine
  ↗ 948
• Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

  Cathrine Ørskov, L. Rabenhøj, André Wettergren, et al.·1994·Diabetes
  ↗ 888
• Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

  Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon, et al.·2001·Diabetes
  ↗ 882OA